Green Park & Golf Ventures II, LLC purchased $500K of MOBI (indirect holdings)

Green Park & Golf Ventures II, LLC purchased 33,333 indirectly-held shares of Mobia Medical, Inc. (MOBI) at $15.00 ($0.50M total) on 2026-05-11.

Original reporting
SEC EDGAR · Green Park & Golf Ventures II, LLC
Published Jun 29, 2026, 11:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MOBI
Bullish
medium confidence
Mentioned
$MOBI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MOBIBullishLow
01

Why it matters

The newest concrete fact is the disclosed purchase size, price, and post-transaction holdings for a 10% owner; it may slightly influence sentiment but does not change the company’s fundamentals in the text.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to materially move the stock without additional company-specific news.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but the article does not clarify intent, whether the holder is funding purchases, or whether other insiders/holders are acting similarly.

Relevance 5/10Novelty 5/10Timing: after-hours/filing timestamp (2026-06-29) for a May 11 purchase disclosure

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Mobia Medical, Inc.

Company-level read

Ticker impact

$MOBIBullishMedium confidence
Context

Green Park & Golf Ventures II, LLC (10% owner) filed a Form 4 for an indirect open-market purchase of 33,333 MOBI shares at $15.

Expected impact

Likely modest/short-lived sentiment support; not enough to drive a sustained repricing without accompanying company-specific catalysts.

Evidence & confidence

Form 4 insider buying can be read as confidence, but the article lacks new operational, financial, or regulatory developments and provides no 10b5-1 plan context.

Market effects

No sector read-across; this is a single-company ownership transaction.

None indicated.

None indicated.

Counterpoint

Indirect open-market purchases by large holders can be routine rebalancing or tax/estate-related rather than a strong forward-looking signal.

Key entities

  • Mobia Medical, Inc.

    Subject of the Form 4 insider transaction; ticker MOBI.

  • Green Park & Golf Ventures II, LLC

    10% owner who purchased $499,995 of MOBI shares indirectly.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MOBIMed

What Mobia Medical (MOBI) Said on Its Q3 Earnings Call

Mobia Medical (MOBI) reported Q3 earnings with a net loss of $17.3M ($0.52 per share), improved from last year. Gross margin rose to 83.2%. Operating expenses increased to $31.5M due to higher personnel costs. The company cited positive impacts from revised stroke recovery guidelines and expects to publish clinical evidence in 2027.

$MOBIHigh

Mobia Medical Reports Third Quarter 2026 Financial Results

Mobia Medical, Inc. (MOBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mobia Medical Reports Third Quarter 2026 Financial Results Delivers revenue growth of 73% in the third quarter and raises full year 2026 revenue guidance Austin, Texas, November 5, 2026 — Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke

$MOBIHigh

Mobia Medical stock jumps on stroke guideline inclusion

Mobia Medical Inc (MOBI) shares rose 7.2% premarket after the American Heart Association included its paired vagus nerve stimulation in 2026 stroke rehabilitation guidelines. The Vivistim Paired VNS System is the only FDA-approved system for this treatment, which may improve upper-limb function. Stroke is a leading cause of long-term disability in the U.S.